Leukocyte chemotaxis is an important aspect of host defense mechanisms. The assay method originally described by Boyden (1) for the measurement of leukocyte chemotaxis in vitro had been extensively used in accordance with the original method or with various modifications (2-6). Although the Boyden techniques made powerful con tributions to the studies performed in this laboratory on leukocyte chemotaxis (6-10), we felt that it was still an urgent matter to improve the Boyden chamber to make it more economical and reliable as well as more easy to use. The present paper will describe a simplified, highly sensitive and reproducible modification of the Boyden technique for the measurement of leukocyte chemotaxis using a new disposable device made of plastic.
A commercially available immunoassay plate purchased from Eflab Oy Co., Finland (Titertec, Microtitration equipment, Flat bottom type with 12 holes that were each 7 mm in diameter and 11 mm in depth) was used for the lower chambers of the chemo taxis device. Another plate of the same type, of which the bottom of the holes had been filed off by us, was placed upon the above described lower chambers to assemble the chemotaxis device ( Fig. 1 ). Between each upper chamber and lower chamber, a polycarbonate filter (11-13 mm in diameter, Nuclepore
Corp., Pleasanton, CA, U.S.A.) with pores of 2 ,cam in diameter was tightly sandwiched with the aid of silicon grease (Toray Silicon, Tokyo, Japan) and rubber bands. Prior to placing the filter on the lower chamber, a test solution (4.2 ml) of chemoat tractant samples dissolved in RPMI-1640 medium (Nissui Seiyaku Co., Tokyo, Japan) was applied into the lower chamber, being careful to avoid air bubbles. and finally heating at 56°C for 30 min. Normal rat serum treated at 56°C for 30 min was designated as heat-inactivated serum, and used as a control serum with no chemotactic activity.
After the cell suspension (0.3 ml) was placed in the upper chambers, the chemo taxis device was kept at 37'C in a C02 incubator with 5% C02 and 100% humidity for a suitable period. Then the fluid in the upper chamber was decanted away and remaining fluid and cells in the upper chamber were completely washed away by blowing a jet of water through a pipette. The filter and entire fluid in the lower chamber were then transferred into a test tube and agitated to make a cell suspension. Cells adhering on the inner surface of the lower chamber were detached by blowing a stream of the medium through a capped pipette and pooled with the above cell suspension. The cell number was then counted in a hemocytometer. Migration rate was calculated as follows:
(Number of leukocytes collected from the lower chamber/Number of leukocytes applied in the upper chamber) x100(%). Boyden chambers were incubated for 80 min for the cel! migration. Each point represents the mean±S.E.M. of six determinations. Significant difference (P<0.01) from respective control is indicated by an asterisk. (A): Leukocyte chemotaxis in response to zymosan-activated serum. Zymosan-activated serum was applied to in dicated concentrations in the lower chambers. Heat-inactivated normal rat serum was supplemented to adjust final serum concentration below the filter to 2.5%. A group of the lower chambers con tained medium only (F~) and another group of the Boyden chambers contained 2.5% of zymosan activated serum in both the upper and lower chambers (A).
(B): Leukocyte chemotaxis in response to FMLP. FMLP dissolved in the medium containing 1% bovine serum albumin was applied in the lower chamber.
(C): Leukocyte chemotaxis in response to LTB4. LTB4 (kindly supplied by Ono Pharmaceutical Co., Osaka, Japan) dissolved in the medium containing 0.2% bovine serum albumin was applied in the lower chamber.
The leukocyte suspension was applied in the upper chamber charged with 2.5% zymosan-activated serum in the lower chamber, and then the number of leukocytes migrated into the lower chamber was determined after the incubation for 40, 80 and 120 min. The data values obtained were (1.08±0.13) x 106, (1.60±0.09) x 106 and (1.66±0.06)x106 cells for the respective times, i.e., the number of leukocytes migrated into the lower chamber increased with the passage of time up to 80 min and then leveled off. When zymosan-activated serum was applied at various concentrations in the lower chamber, a dose-response relationship in the migration was observed as summarized in Fig. 2 (A) . Background levels of the migration rate observed with 2.5% heat inactivated normal rat serum and the plain RPMI-1640 medium were 1.93±0.27 and 0.80±0.10%, respectively. The migration rate at 0.05% zymosan-activated serum was 2.77±0.07%, i.e., significantly higher than the background levels. When 2.5% zymosan activated serum was applied in both the upper and lower chambers, the migration rate was 4.9±0.9%, while 2.5% zymosan-activated serum placed only in the lower chamber caused a migration rate of nearly 60%. Therefore, this assay system was evidently capable of detecting the chemotactic activity for 0.05% zymosan-activated serum and distinguishing chemotactic migration of the cells from their random movement.
